Nintedanib for treating progressive fibrosing interstitial lung diseases

被引：4
|
作者：
Adler, Amanda, I [1 ]
Guo, Yelan [2 ]
Thiam, Aminata [2 ]
Elliott, Nicole [2 ]
Patel, Sanjeev [3 ]
机构：
[1] Biomed Res Ctr, Oxford Ctr Diabet Endocrinol & Metab, Diabet Trial Unit, Oxford, England
[2] Natl Inst Hlth & Care Excellence, Manchester, Lancs, England
[3] Kings Coll Hosp London, Dept Rheumatol, London, England
来源：
LANCET RESPIRATORY MEDICINE | 2021年 / 9卷 / 12期
关键词：
D O I：
10.1016/S2213-2600(21)00517-8
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
[No abstract available]
引用
收藏
页码：E116 / E117
页数：2
相关论文
共 50 条
  • [1] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Kao, Jui-Hung
    Huang, Hsin-Tuan
    Li, Ko-Jen
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 780 - 781
  • [2] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
    Flaherty, K. R.
    Wells, A. U.
    Cottin, V
    Devaraj, A.
    Walsh, S. L. F.
    Inoue, Y.
    Richeldi, L.
    Kolb, M.
    Tetzlaff, K.
    Stowasser, S.
    Coeck, C.
    Clerisme-Beaty, E.
    Rosenstock, B.
    Quaresma, M.
    Haeufel, T.
    Goeldner, R-G
    Schlenker-Herceg, R.
    Brown, K. K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (18): : 1718 - 1727
  • [3] Nintedanib in progressive fibrosing interstitial lung diseases
    Hadjiski, D.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2020, 79 (04): : 393 - 394
  • [4] Nintedanib in Progressive Fibrosing Interstitial Lung Diseases Reply
    Flaherty, Kevin R.
    Wells, Athol U.
    Brown, Kevin K.
    NEW ENGLAND JOURNAL OF MEDICINE, 2020, 382 (08): : 781 - 781
  • [5] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
    Vincent Cottin
    Luca Richeldi
    Ivan Rosas
    Maria Otaola
    Jin Woo Song
    Sara Tomassetti
    Marlies Wijsenbeek
    Manuela Schmitz
    Carl Coeck
    Susanne Stowasser
    Rozsa Schlenker-Herceg
    Martin Kolb
    Respiratory Research, 22
  • [6] Nintedanib and immunomodulatory therapies in progressive fibrosing interstitial lung diseases
    Cottin, Vincent
    Richeldi, Luca
    Rosas, Ivan
    Otaola, Maria
    Song, Jin Woo
    Tomassetti, Sara
    Wijsenbeek, Marlies
    Schmitz, Manuela
    Coeck, Carl
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Kolb, Martin
    RESPIRATORY RESEARCH, 2021, 22 (01)
  • [7] Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
    Wollin, Lutz
    Distler, Joerg H. W.
    Redente, Elizabeth F.
    Riches, David W. H.
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    Maher, Toby M.
    Kolb, Martin
    EUROPEAN RESPIRATORY JOURNAL, 2019, 54 (03)
  • [8] Progressive fibrosing interstitial lung diseases: A new concept and indication of nintedanib
    Makino, Shigeki
    MODERN RHEUMATOLOGY, 2021, 31 (01) : 13 - 19
  • [9] From Bench to Bedside: Nintedanib for Progressive Fibrosing Interstitial Lung Diseases
    Garlick, Kristopher
    Wollin, Lutz
    Distler, Joerg
    Stowasser, Susanne
    Schlenker-Herceg, Rozsa
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (07) : 822 - 822
  • [10] FROM BENCH TO BEDSIDE: NINTEDANIB FOR PROGRESSIVE FIBROSING INTERSTITIAL LUNG DISEASES
    Wollin, L.
    Distler, J.
    Redente, E.
    Riches, D.
    Stowasser, S.
    Schlenker-Herceg, R.
    RESPIROLOGY, 2019, 24 : 171 - 171
12345